hrcak mascot   Srce   HID

Pregledni rad

Azithromycin and Chronic Respiratory Diseases

Neven Tudorić

Puni tekst: hrvatski, pdf (104 KB) str. 165-170 preuzimanja: 244* citiraj
APA 6th Edition
Tudorić, N. (2018). Azitromicin i kronične plućne bolesti. Medicus, 27 (2 Sumamed), 165-170. Preuzeto s
MLA 8th Edition
Tudorić, Neven. "Azitromicin i kronične plućne bolesti." Medicus, vol. 27, br. 2 Sumamed, 2018, str. 165-170. Citirano 10.08.2020.
Chicago 17th Edition
Tudorić, Neven. "Azitromicin i kronične plućne bolesti." Medicus 27, br. 2 Sumamed (2018): 165-170.
Tudorić, N. (2018). 'Azitromicin i kronične plućne bolesti', Medicus, 27(2 Sumamed), str. 165-170. Preuzeto s: (Datum pristupa: 10.08.2020.)
Tudorić N. Azitromicin i kronične plućne bolesti. Medicus [Internet]. 2018 [pristupljeno 10.08.2020.];27(2 Sumamed):165-170. Dostupno na:
N. Tudorić, "Azitromicin i kronične plućne bolesti", Medicus, vol.27, br. 2 Sumamed, str. 165-170, 2018. [Online]. Dostupno na: [Citirano: 10.08.2020.]

Soon after it was introduced in everyday clinical practice, azithromycin became widely used for the treatment of a number of bacterial infections, especially those affecting the respiratory tract. Over time, a growing body of research found that macrolides exert significant immunomodulatory effects, thus significantly expanding indications for azithromycin, a macrolide antibiotic with numerous advantages over the other antibiotics from its class. As opposed to short-term use of azithromycin as an antimicrobial agent, its immunomodulatory effect is presented only after long-term use over a course of several months. This paper briefly addresses the use of azithromycin in patients with chronic respiratory diseases where the effects of the drug are based on its immunomodulatory effects.

Ključne riječi
azithromycin; respiratory tract; bacterial infections; immunomodulatory effect; chronic respiratory diseases

Hrčak ID: 214610



Posjeta: 329 *